Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tvardi Therapeutics, Inc. | 12,000 | reported | 17 Apr 2025 | tx 3+30,441 |
| CymaBay Therapeutics, Inc. | 0 | reported | 22 Mar 2024 | tx 87+4,960,948−4,960,948 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Apr 2025 | GRANT_AWARD | Tvardi Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 15 Apr 2025 | GRANT_AWARD | Tvardi Therapeutics, Inc. | 8,047 | — | deriv |
| 15 Apr 2025 | GRANT_AWARD | Tvardi Therapeutics, Inc. | 10,394 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 310,420 | — | |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 96,250 | — | |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 357,500 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 800,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 649,999 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 284,712 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 536,032 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 314,120 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 146,875 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 621,101 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 90,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 47,916 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 50,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 39,375 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 88,351 | — | deriv |
| 13 Mar 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 3,125 | 11.69 USD | |
| 13 Mar 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 1 | 2.94 USD | |
| 13 Mar 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 2,288 | 5.78 USD | |
| 13 Mar 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 22,076 | 4.05 USD | |
| 13 Mar 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 14,372 | 8.43 USD | |
| 13 Mar 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 11,649 | 10.00 USD | |
| 13 Mar 2024 | EXERCISE | CymaBay Therapeutics, Inc. | 14,625 | 1.06 USD |
2 purchases reported after at least 12 months of silence — most recent on 06 Jun 2022.